Particle Data Platform

Ozempic and Cravings: How GLP-1 Drugs Work for Addiction

7/2/202645 min

Can a weight-loss medication actually cure your deepest cravings? Discover how GLP-1 drugs are revolutionizing the landscape of addiction recovery.

Find mental health and addiction treatment near you: https://recovery.com/

In this episode of Recoverable, host Terry Maguire sits down with Dr. Steven Klein, an expert medical professional specializing in addiction medicine who also brings his own powerful lived experience of nine years in long-term recovery. Together, they explore the fascinating science of drug repurposing—shifting medications like semaglutide and tirzepatide (widely known under brand names like Ozempic, Wegovy, Mounjaro, and Zepbound) from type 2 diabetes and chronic weight management over to the frontlines of substance use disorder treatment. Dr. Klein breaks down how these powerful gut-brain peptides quiet persistent "food noise" and "drug noise" by directly targeting the mesolimbic dopamine system, which controls the brain’s fundamental reward circuitry.

Whether discussing alcohol use disorder, opioid use disorder, nicotine dependence, or behavioral addictions like compulsive gambling, this deep-dive addresses the critical neurobiology behind how GLP-1 for addiction functions as a substance-agnostic tool. You’ll learn about recent groundbreaking clinical data showing a 50% drop in substance-related mortality, the clinical reality of off-label prescribing, common GI side effects, and what happens to internal cravings once you stop taking the medication. Dr. Klein shares his profound "record needle" analogy, showing how these treatments temporarily quiet internal noise so individuals can learn a completely new behavioral song. If you or a loved one are exploring cutting-edge medical tools to support sustainable recovery, reduce relapse, and reclaim your agency, this episode provides essential context, breaking down the artificial boundaries between physical metabolic health and mental health.

Watch the full conversation to unlock the future of highly personalized behavioral care. Don't forget to like this video, subscribe to the channel, and share your thoughts or personal experiences in the comments section below!

Chapters: 00:00 – Intro 01:14 – How GLP-1s Transformed My Relationship with Food 06:27 – How Weight Loss Drugs Ended Up on the Addiction Radar 09:05 – How GLP-1s Treat the Core Circuitry of Addiction 11:14 – What Are the Side Effects of GLP-1 Medications? 15:18 – How Do GLP-1 Drugs Actually Work for Addiction? 18:00 – Does Brain Rewiring Continue After Stopping GLP-1s? 23:49 – Are GLP-1s FDA-Approved for Addiction Treatment? 26:53 – Do GLP-1s Cause Anhedonia or Suicidal Thoughts? 42:31 – Can You Take GLP-1s for Addiction Without Losing Weight?

Questions the Video Answers:

  1. How do GLP-1 drugs work for addiction treatment?
  2. Can Ozempic or Wegovy help reduce alcohol cravings?
  3. What is the success rate of GLP-1 medications for substance use disorders?
  4. How do diabetes and weight-loss drugs quiet food noise in the brain?
  5. Are GLP-1 medications FDA-approved to treat alcohol or opioid addiction?
  6. What are the common side effects of using GLP-1s for addiction recovery?
  7. Do cravings return after you stop taking semaglutide or tirzepatide?
  8. Can you take GLP-1 medications for addiction if you don't want to lose weight?
  9. How do GLP-1 agonists impact the brain's dopamine reward system?
  10. Is it safe to combine GLP-1s with other addiction medications like buprenorphine?
  11. Will health insurance cover Ozempic or Zepbound if prescribed off-label for addiction?
  12. Can GLP-1 medications help treat behavioral addictions like gambling or sex addiction?
  13. What did the British Medical Journal study find regarding GLP-1s and substance mortality?
  14. Does taking weight-loss drugs cause anhedonia or a general loss of joy?
  15. How long will it take for the FDA to approve GLP-1s for addiction?

#GLP1ForAddiction #OzempicForAddiction #AddictionRecovery

Clips

Transcript preview

First 90 seconds
  1. Steven Klein· Guest0:00

    This year, 10 to 12% of Americans will be on a GLP-1.

  2. Terri McGuire· Host0:03

    [instrumental music] Dr. Steven Klein, who specializes in addiction medicine, joins us to discuss innovative treatments, including the role of GLP-1s in substance use disorder recovery.

  3. Steven Klein· Guest0:14

    Addiction is a problem with the brain, and now we have a really good medication to potentially change the brain, and that's gonna change the way that we view addiction.

  4. Terri McGuire· Host0:21

    [keyboard typing] Welcome to Recoverable. I'm your host, Terri McGuire. The history of medicine is full of happy accidents, where a drug designed for one specific use ends up being used for something else and revolutionizing another field. For instance, the hair growth drug Rogaine was originally designed to treat high blood pressure, and Viagra was used to treat high blood pressure and chest pain. This phenomenon is known as drug repurposing, and it's exactly what we're seeing now with GLP-1s. Developed to manage Type 2 diabetes, they are now widely used for chronic weight management, and today we're gonna discuss the fact that they're also being used to treat addictions. And joining us now is Dr. Steven Klein, who not only is an expert in this topic, but has lived experience with it as well. Dr. Klein, welcome back.

  5. Steven Klein· Guest1:12

    Thank you so much for having me.

  6. Terri McGuire· Host1:13

    Thank you. So GLP-1s- Hmm ... that's a, that's a shift.

  7. Steven Klein· Guest1:17

    Sure.

  8. Terri McGuire· Host1:17

    How did this come about? And tell us how it has worked for you in your life.

  9. Steven Klein· Guest1:20

    Sure. So I'll start with my story first.

  10. Terri McGuire· Host1:23

    Yeah.

  11. Steven Klein· Guest1:23

    Um, so, like, we covered a little bit in the last episode. I'm a person in long-term recovery. I've been sober for the past nine years.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.